Epilepsy Clinical Trials in New York

Showing 61-80 of 141 trials

Long-term Cardiac Monitoring in Epilepsy

NCT03955432

The purpose of this research study to investigate, classify, and quantify chronic cardiac rhythm disorders in three groups of patients with epilepsy (intractable focal epilepsy, controlled focal epilepsy and symptomatic generalized epilepsy). Patients with epilepsy have a higher risk for cardiac complications than the general population. With this study, we aim to understand more about these potential complications in patients with epilepsy and assess if treatments for cardiac problems should be evaluated more carefully in patients with epilepsy.

Focal EpilepsyIntractable EpilepsyEpileptic Encephalopathy+3 more

Northwell Health7 participantsStarted Mar 2019

New York, New York, United States

COMPLETEDPhase 3< 1 mile

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

NCT02544763

This trial consists of 2 parts: a double-blinded phase and an open-label extension phase. The blinded phase only will be described in this record. Participants will receive 1 of 2 doses of GWP42003-P or matching placebo. The primary clinical hypothesis is that there will be a difference between GWP42003-P and placebo in their effect on seizure frequency.

Tuberous Sclerosis ComplexSeizures

Jazz Pharmaceuticals224 participantsStarted Apr 2016

Birmingham, Alabama, United States • Little Rock, Arkansas, United States • Los Angeles, California, United States +41 more locations

Long-term Cardiac Monitoring in Epilepsy

A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)

Epilepsy Trials in Other Cities

Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

Study to Evaluate the Efficacy and Safety of Perampanel as Monotherapy or First Adjunctive Therapy in Subjects With Partial Onset Seizures With or Without Secondarily Generalized Seizures or With Primary Generalized Tonic-Clonic Seizures

Brivaracetam Safety and Efficacy Follow-up Study in Subjects With Epilepsy

Staccato Alprazolam and Photoparoxysmal Response

Rufinamide Given as Adjunctive Therapy in Participants With Refractory Partial Seizures

A Phase 2, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of TAK-935 (OV935) as an Adjunctive Therapy in Pediatric Participants With Developmental and/or Epileptic Encephalopathies

Inpatient, Dose-Ranging Study of Staccato Alprazolam in Epilepsy With Predictable Seizure Pattern

A Study to Assess the Safety and Efficacy of Lacosamide Versus Placebo (a Pill Without Active Medication) in Patients With Idiopathic Generalised Epilepsy Who Are Already Taking Anti-epileptic Medications

Childhood Absence Epilepsy Rx PK-PD-Pharmacogenetics Study

Study to Test the Safety and Efficacy of Padsevonil as Adjunctive Treatment of Focal-onset Seizures in Adult Subjects With Drug-resistant Epilepsy

Phase 2 Efficacy, Safety, and Tolerability Study of Natalizumab in Focal Epilepsy

A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601

Neuroimaging Biomarker for Seizures

Microburst Vagus Nerve Stimulator (VNS) Therapy Feasibility Study

Diffusion MRI-1 Imaging Database

A Safety, Efficacy, and Tolerability Trial of Pregabalin as Add-On Treatment in Pediatric Subjects <4 Years of Age With Partial Onset Seizures.

Study Of The Safety And Efficacy Of Lyrica In The Treatment Of Newly Diagnosed Partial Epilepsy

Other Conditions in New York